Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 946803, 7 pages
http://dx.doi.org/10.1155/2014/946803
Research Article

Potassium Concentration on Admission Is an Independent Risk Factor for Target Lesion Revascularization in Acute Myocardial Infarction

Department of Cardiology, Cardiovascular Center, National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Chuo-ku, Kumamoto 860-0008, Japan

Received 6 August 2013; Accepted 22 October 2013; Published 12 January 2014

Academic Editors: D. G. Karalis, I. Misumi, P. Quax, and F. Thuny

Copyright © 2014 Tsuyoshi Honda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Clausen, “Hormonal and pharmacological modification of plasma potassium homeostasis,” Fundamental and Clinical Pharmacology, vol. 24, no. 5, pp. 595–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. P. Karlsberg, P. E. Cryer, and R. Roberts, “Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality,” American Heart Journal, vol. 102, no. 1, pp. 24–29, 1981. View at Google Scholar · View at Scopus
  3. J. E. Nordrehaug, “Malignant arrhythmia in relation to serum potassium in acute myocardial infarction,” American Journal of Cardiology, vol. 56, no. 6, pp. 20D–23D, 1985. View at Google Scholar · View at Scopus
  4. J. E. Madias, B. Shah, G. Chintalapally, G. Chalavarya, and N. E. Madias, “Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome,” Chest, vol. 118, no. 4, pp. 904–913, 2000. View at Google Scholar · View at Scopus
  5. K. Foo, N. Sekhri, A. Deaner et al., “Effect of diabetes on serum potassium concentrations in acute coronary syndromes,” Heart, vol. 89, no. 1, pp. 31–35, 2003. View at Google Scholar · View at Scopus
  6. R. P. Karlsberg, P. E. Cryer, and R. Roberts, “Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality,” American Heart Journal, vol. 102, no. 1, pp. 24–29, 1981. View at Google Scholar · View at Scopus
  7. T. Clausen, “Adrenergic control of Na+-K+-homeostasis,” Acta Medica Scandinavica. Supplementum, vol. 672, pp. 111–115, 1983. View at Google Scholar
  8. P. S. Monraats, N. M. M. Pires, W. R. P. Agema et al., “Genetic inflammatory factors predict restenosis after percutaneous coronary interventions,” Circulation, vol. 112, no. 16, pp. 2417–2425, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. L. R. Queen, B. Xu, K. Horinouchi, I. Fisher, and A. Ferro, “β2-adrenoceptors activate nitric oxide synthase in human platelets,” Circulation Research, vol. 87, no. 1, pp. 39–44, 2000. View at Google Scholar · View at Scopus
  10. A. F. Chen, J. Ren, and C.-Y. Miao, “Nitric oxide synthase gene therapy for cardiovascular disease,” Japanese Journal of Pharmacology, vol. 89, no. 4, pp. 327–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Thygesen, J. S. Alpert, and H. D. White, “Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction,” Circulation, vol. 116, pp. 2634–2653, 2007. View at Google Scholar
  12. E. Garcia-Cantu, C. Spaulding, T. Corcos et al., “Stent implantation in acute myocardial infarction,” American Journal of Cardiology, vol. 77, no. 7, pp. 451–454, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Pasceri, G. Patti, G. Speciale, C. Pristipino, G. Richichi, and G. Di Sciascio, “Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction,” American Heart Journal, vol. 153, no. 5, pp. 749–754, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Schampaert, E. A. Cohen, M. Schlüter et al., “The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS),” Journal of the American College of Cardiology, vol. 43, no. 6, pp. 1110–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Takaichi, F. Takemoto, Y. Ubara, and Y. Mori, “Analysis of factors causing hyperkalemia,” Internal Medicine, vol. 46, no. 12, pp. 823–829, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Masuo, G. W. Lambert, M. D. Esler, H. Rakugi, T. Ogihara, and M. P. Schlaich, “The role of sympathetic nervous activity in renal injury and end-stage renal disease,” Hypertension Research, vol. 33, no. 6, pp. 521–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Jamerson, S. Julius, T. Gudbrandsson, O. Andersson, and D. O. Brant, “Reflex sympathetic activation induces acute insulin resistance in the human forearm,” Hypertension, vol. 21, no. 5, pp. 618–623, 1993. View at Google Scholar · View at Scopus
  18. P. G. Hsiao, C. A. Hsieh, C. F. Yeh et al., “Early prediction of acute kidney injury in patients with acute myocardial injury,” Journal of Critical Care, vol. 525, pp. e1–e7, 2012. View at Google Scholar
  19. M. J. Brown, D. C. Brown, and M. B. Murphy, “Hypokalemia from beta2-receptor stimulation by circulating epinephrine,” The New England Journal of Medicine, vol. 309, no. 23, pp. 1414–1419, 1983. View at Google Scholar · View at Scopus
  20. C. G. Solomon, T. H. Lee, E. F. Cook et al., “Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: The Multicenter Chest Pain Study Experience,” American Journal of Cardiology, vol. 63, no. 12, pp. 772–776, 1989. View at Google Scholar · View at Scopus
  21. V. Culić, D. Eterović, D. Mirić, and N. Silić, “Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors,” American Heart Journal, vol. 144, pp. 1012–1017, 2002. View at Google Scholar
  22. S. A. Grossman, D. F. M. Brown, Y. Chang et al., “Predictors of delay in presentation to the ED in patients with suspected acute coronary syndromes,” American Journal of Emergency Medicine, vol. 21, no. 5, pp. 425–428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K. K. Ho, S. W. Lee, S. B. S. Ooi, F. Lateef, S. H. Lim, and V. Anantharaman, “Acute coronary syndrome—factors causing delayed presentation at the Emergency Department,” Annals of the Academy of Medicine Singapore, vol. 31, no. 3, pp. 387–392, 2002. View at Google Scholar · View at Scopus
  24. H. Fujimoto, S. Tao, J. Masuda et al., “The efficacy of bare metal stent implantation for patients with acute myocardial infarction in the drug-eluting stent era,” Journal of Cardiology, vol. 51, no. 3, pp. 189–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. I. M. Shugman, L. Hee, C. J. Mussap et al., “Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularization,” American Heart Journal, vol. 165, pp. 591–599, 2013. View at Google Scholar
  26. H. M. Sadeghi, G. W. Stone, C. L. Grines et al., “Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction,” Circulation, vol. 108, no. 22, pp. 2769–2775, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Okura, H. Taguchi, T. Kubo et al., “Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study,” Heart, vol. 93, no. 10, pp. 1219–1225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Cristea, G. W. Stone, R. Mehran, A. J. Kirtane, and S. J. Brener, “Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing,” American Heart Journal, vol. 162, no. 1, pp. 173–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-Y. Choi, A. Maehara, E. Cristea et al., “Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy),” American Journal of Cardiology, vol. 109, no. 4, pp. 455–460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. Nordrehaug and G. Von Der Lippe, “Hypokalaemia and ventricular fibrillation in acute myocardial infarction,” British Heart Journal, vol. 50, no. 6, pp. 525–529, 1983. View at Google Scholar · View at Scopus
  31. J. E. Nordrehaug, K. A. Johannessen, and G. Von Der Lippe, “Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction,” Circulation, vol. 71, no. 4, pp. 645–649, 1985. View at Google Scholar · View at Scopus
  32. A. Goyal, J. A. Spertus, K. Gosch et al., “Serum potassium levels and mortality in acute myocardial infarction,” The Journal of the American Medical Association, vol. 307, no. 2, pp. 157–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. B. D. Hoit, D. P. Suresh, L. Craft, R. A. Walsh, and S. B. Liggett, “β2-Adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals,” American Heart Journal, vol. 139, no. 3, pp. 537–542, 2000. View at Google Scholar · View at Scopus
  34. K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck, “β2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals,” American Journal of Hypertension, vol. 18, no. 7, pp. 1009–1014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Chen, M. S. Lipkowitz, R. M. Salem et al., “Progression of chronic kidney disease: adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis,” American Journal of Nephrology, vol. 32, no. 1, pp. 23–30, 2010. View at Publisher · View at Google Scholar · View at Scopus